Failure to increase 5-fluorouracil activity with interferon-alpha 2a in the treatment of advanced colorectal cancer

Eur J Cancer. 1995;31A(1):127. doi: 10.1016/0959-8049(94)00469-l.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Colorectal Neoplasms / therapy*
  • Female
  • Fluorouracil / therapeutic use*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Fluorouracil